Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature
Acta Dermato-Venereologica · 2024
DOI: 10.2340/actadv.v104.40453 ↗Kurz gefasst
Fallbericht in der Zeitschrift Acta Dermato-Venereologica, 2024. Verfasst von Clélia Vanhaecke und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology department, Robert Debré Hospital, Reims University Hospital, Reims, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Photosensitivity Disorders, Remission Induction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
is missing (Short communication)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology department, Robert Debré Hospital, Reims University Hospital, Reims, France.
- Reims Champagne-Ardenne University, Dermatology department, Reims University Hospital, IRMAIC EA7509, Reims, France. mviguier@chu-reims.fr.
Zitieren
APA
Clélia Vanhaecke, & Manuelle Viguier (2024). Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v104.40453
Vancouver
Clélia Vanhaecke, Manuelle Viguier. Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature. Acta Dermato-Venereologica. 2024. doi:10.2340/actadv.v104.40453
BibTeX
@article{ClliaVanhaecke2024,
author = {Clélia Vanhaecke and Manuelle Viguier},
title = {Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature},
journal = {Acta Dermato-Venereologica},
year = {2024},
doi = {10.2340/actadv.v104.40453}
}
EUVIMED